NOVC.DE
Price:
$91.4
Market Cap:
$1.38T
Novo Nordisk A/S is a healthcare company, which engages in the research, development, manufacture, and marketing of pharmaceutical products. The firm is also engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The firm operates through two business segments: diabetes and obesity care, and biopharmaceuticals. The firm's diabetes and obesity care segment covers insulin, GLP-1, other protein-related products, such as glucagon, protein-related delivery systems and needles, and oral anti-diabetic drugs. The firm's biopharmaceuticals segment covers the therapy areas of hemophilia care, growth hormone therapy and hormone replacement therapy. The firm also ...[Read more]
Industry
Medical - Pharmaceuticals
IPO Date
2001-06-07
Stock Exchange
XETRA
Ticker
NOVC.DE
According to Novo Nordisk A/S’s latest financial reports and current stock price. The company's current ROE is 77.86%. This represents a change of 293.96% compared to the average of 19.76% of the last 4 quarters.
The mean historical ROE of Novo Nordisk A/S over the last ten years is 72.62%. The current 77.86% ROE has changed 7.22% with respect to the historical average. Over the past ten years (40 quarters), NOVC.DE's ROE was at its highest in in the March 2024 quarter at 25.69%. The ROE was at its lowest in in the December 2020 quarter at 14.71%.
Average
72.62%
Median
72.30%
Minimum
66.51%
Maximum
83.78%
Discovering the peaks and valleys of Novo Nordisk A/S ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 18.08%
Maximum Annual ROE = 83.78%
Minimum Annual Increase = -10.38%
Minimum Annual ROE = 66.51%
| Year | ROE | Change |
|---|---|---|
| 2024 | 70.38% | -10.38% |
| 2023 | 78.53% | 18.08% |
| 2022 | 66.51% | -1.48% |
| 2021 | 67.50% | 1.45% |
| 2020 | 66.54% | -1.61% |
| 2019 | 67.63% | -9.24% |
| 2018 | 74.52% | -2.65% |
| 2017 | 76.54% | -8.63% |
| 2016 | 83.78% | 12.88% |
| 2015 | 74.22% | 12.93% |
The current ROE of Novo Nordisk A/S (NOVC.DE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
71.81%
5-year avg
69.89%
10-year avg
72.62%
Novo Nordisk A/S’s ROE is greater than Walgreens Boots Alliance, Inc. (-70.17%), less than Henry Schein, Inc. (11.40%), greater than Shop Apotheke Europe N.V. (-7.15%), greater than Baxter International Inc. (-4.77%), less than Koninklijke Philips N.V. (1.41%), less than Synlab AG (10.58%), greater than DENTSPLY SIRONA Inc. (-47.74%), less than PharmaSGP Holding SE (57.04%), greater than ViewRay, Inc. (-85.33%), less than CompuGroup Medical SE & Co. KGaA (4.19%),
| Company | ROE | Market cap |
|---|---|---|
| -70.17% | $8.90B | |
| 11.40% | $9.38B | |
| -7.15% | $1.61B | |
| -4.77% | $29.61B | |
| 1.41% | $43.45B | |
| 10.58% | $2.43B | |
| -47.74% | $3.76B | |
| 57.04% | $333.86M | |
| -85.33% | $207.23M | |
| 4.19% | $1.17B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Novo Nordisk A/S using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Novo Nordisk A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Novo Nordisk A/S's ROE?
How is the ROE calculated for Novo Nordisk A/S (NOVC.DE)?
What is the highest ROE for Novo Nordisk A/S (NOVC.DE)?
What is the 3-year average ROE for Novo Nordisk A/S (NOVC.DE)?
What is the 5-year average ROE for Novo Nordisk A/S (NOVC.DE)?
How does the current ROE for Novo Nordisk A/S (NOVC.DE) compare to its historical average?